vimarsana.com

Page 87 - பல்கலைக்கழகம் ஆஃப் பிட்ஸ்பர்க் மருத்துவ மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Could You Have Prediabetes or Diabetes and Not Know It? The Signs

With 88 million Americans or approximately 1 in every 3 adults, suffering from prediabetes in this country (and 34 million Americans, or 1 in 10, with full-blown type 2 diabetes), many people are walking around with a ticking time bomb in their bodies, and don t even know they have the condition. Prediabetes is when your blood sugar level is higher than it should be for optimal health, but not high enough for your doctor to diagnose the disease. It s also known as impaired fasting glucose or glucose intolerance. The scary part is, 90 percent of those with prediabetes don’t know that they have it. We have all heard that excessive thirst or urinating more often than normal is a sign that you could have diabetes, but what are the telltale signals that you may have prediabetes? Why does it matter? The sooner you find out the better, for your health and to know that changing your lifestyle can alter the course of the disease and head it off at the pass.

ENDRA Life Sciences and GE Healthcare extend collaboration

ENDRA Life Sciences and GE Healthcare extend collaboration Rating saved ENDRA Life Sciences, the developer of Thermo Acoustic Enhanced Ultrasound (TAEUS), has renewed its collaboration agreement with GE Healthcare, extending the agreement s previous 12-month term by an additional two years. TAEUS visualizes tissue in a way that is comparable to MR, according to ENDRA, but at a small fraction of the cost and at the point of care. The technology is designed to work in concert with the over one million ultrasound systems in use globally today. Through the collaboration, GE will continue to support ENDRA s efforts to commercialize a fatty liver diagnostic application by facilitating introductions to its clinical ultrasound customers worldwide. In return, ENDRA will afford GE certain rights of first offer with respect to manufacturing and licensing the application.

Pa Justices Say UPMC Doctors Not Liable For Clinic Shooting

ADVERTISEMENT ADVERTISEMENT Pa. Justices Say UPMC Doctors Not Liable For Clinic Shooting Law360 (December 22, 2020, 9:27 PM EST) A pair of University of Pittsburgh Medical Center doctors who considered but did not complete the involuntary commitment process for a patient who later carried out a mass shooting at a Pittsburgh psychiatric hospital can t be held liable under Pennsylvania law, the state s high court ruled Tuesday. John Shick was still a voluntary outpatient when seen by the two UPMC physicians who were making inquiries to their colleagues about having him committed, so they weren t liable under the Mental Health Procedures Act when he fatally shot a therapist and wounded six other people at Western Psychiatric Institute and Clinic, the 6-1.

Regeneron drug among COVID treatments going to local patients

Early research and clinical testing of new antibody cocktails have shown promising outcomes in slowing the progression and shortening the duration of COVID-19 for patients with mild to moderate symptoms, and preventing hospitalization.  But the early studies involve small numbers of patients and there is no long-term evidence about its safety and efficacy as clinical research is ongoing. The Infectious Diseases Society of America has come out against routine use of the therapies. The availability of the new treatment comes as COVID-related hospitalizations in Pennsylvania have skyrocketed since Thanksgiving, exceeding numbers early in the pandemic.  Pennsylvania on Tuesday reported 6,151 adults were hospitalized statewide with COVID-19, including more than 1,200 in intensive care. Patients on ventilators jumped to 772 on Tuesday, 34 more than reported Monday. 

NIH pauses clinical trial testing blood thinners on critically ill coronavirus patients

NIH pauses clinical trial testing blood thinners on critically ill coronavirus patients after researchers find high doses may do serious harm The NIH has paused a clinical trial that was testing doses of blood thinners among the most severely ill coronavirus patients Data showed the drugs did not improve their conditions and may have been harmful, but researchers did not elaborate on what the harm was  High dose of anticoagulants have been known to cause internal bleeding, which can lead to the intestines and brain, and cause permanent damage or death  Enrollment of moderately ill hospitalized COVID-19 patients will continue

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.